MedTrace Logo

Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis

NCT06960694 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-02-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of L-carnitine on symptomatic improvement, oxidative stress, and inflammation in mild to moderate knee osteoarthritis patients.

Conditions

Interventions

DRUG

L-carnitine

This group will be treated with tablet L-carnitine 330 mg 3 times daily for 8 weeks

DRUG

Placebo

This group will be treated with tablet Placebo 330 mg 3 times daily for 8 weeks

Sponsors & Collaborators

  • Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

    lead OTHER

Principal Investigators

  • Moumita Ghosh, MBBS · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-28
Primary Completion
2025-11-19
Completion
2025-11-19

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06960694 on ClinicalTrials.gov